ChemoCentryx
CCXI
#3202
Rank
HK$29.09 B
Marketcap
HK$404.56
Share price
0.00%
Change (1 day)
33.25%
Change (1 year)

P/E ratio for ChemoCentryx (CCXI)

P/E ratio on November 25, 2022 (TTM): -27.5

According to ChemoCentryx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -27.5079. At the end of 2021 the company had a P/E ratio of -19.3.

P/E ratio history for ChemoCentryx from 2012 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-19.3-74.8%
2020-76.487.49%
2019-40.8184.03%
2018-14.4-189.27%
201716.1-289.06%
2016-8.5113.41%
2015-7.5018.59%
2014-6.323.76%
2013-6.09-36.49%
2012-9.60

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
9.02-132.81%๐Ÿ‡บ๐Ÿ‡ธ USA
46.4-268.66%๐Ÿ‡บ๐Ÿ‡ธ USA
10.0-136.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
14.8-153.82%๐Ÿ‡บ๐Ÿ‡ธ USA
10.8-139.42%๐Ÿ‡บ๐Ÿ‡ธ USA
21.0-176.32%๐Ÿ‡บ๐Ÿ‡ธ USA
14.3-151.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.35-69.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
54.3-297.30%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.